Tag


Macquarie Park

Filter by year:
COVID-19

COVID-19

As we emerge from the grip of COVID-19, MPID continues to pioneer new ways to innovate, do business and protect the wellbeing of the people who make our community Australia’s innovation capital. In our thriving business community, leaders in technology have adopted new ways to stay productive, leading the way in implementing crisis plans that..
Glasshouse ready for work, rest and play

Glasshouse ready for work, rest and play

John Holland is proud to announce the completion of the Macquarie Park’s latest A-Grade development, Glasshouse.  As part of their 3.2-hectare Macquarie Square precinct, Glasshouse is the first of five buildings in the newest commercial hub in North West Sydney.
Building research centres get boost

Building research centres get boost

The Morrison government is set to pump millions of dollars into two industry-led research centres tasked with modernising the nation’s building industry and developing lower-cost housing solutions for Australians. The dual building and concrete research programs are expected to create savings in the industry of up to $1.8bn over 15 years, with $783m of that from..
AstraZeneca invests $200m in local manufacturing

AstraZeneca invests $200m in local manufacturing

AstraZeneca has committed $200m to its Macquarie Park manufacturing facility.  The North Ryde facility is among the most digitised and innovative in the company’s global network, delivering millions of medicines to millions of patients who need them in Australian, Asia-Pacific and global markets. READ MORE
Optus renews Macquarie Park lease

Optus renews Macquarie Park lease

Optus, an existing Macquarie Park tenant of around 12 years, has renewed its lease with landlords Stockland and AA REIT for another 12 years, with the option to extend for up to 10 years.  Stockland will undertake upgrades to the 84,194 square metre campus, in partnership with Optus. READ MORE